350 results on '"Matter, Matthias S"'
Search Results
2. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma
3. Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers
4. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
5. Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics
6. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.
7. Robust single-cell matching and multimodal analysis using shared and distinct features
8. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells
9. Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments
10. Autoimmune‐Like Hepatitis Related to SARS‐CoV‐2 Vaccination: Towards a Clearer Definition.
11. Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
12. Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report
13. Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study
14. Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
15. PARP-1 selectively impairsKRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma
16. Histomorphological patterns of regional lymph nodes in COVID-19 lungs
17. FOXO1 gene involvement in a non-rhabdomyosarcomatous neoplasm
18. PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma.
19. Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients
20. Reaktionsmuster der lokoregionären Lymphknoten im Abflussgebiet von COVID-19-Lungen
21. Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology
22. Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma
23. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma
24. Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening
25. Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
26. Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX)
27. Resolving the Combinatorial Complexity of Smad Protein Complex Formation and Its Link to Gene Expression
28. High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models
29. Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series.
30. Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series
31. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features
32. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma
33. Supplementary Figure 1 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
34. Supplementary Figure 4 cont. from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
35. Data from Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β
36. Supplementary Methods, Figure Legends 1-5 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
37. Supplementary Table 1 from Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β
38. Supplementary Table 2 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
39. Supplementary Figure 2 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
40. Supplementary Table 1 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
41. Supplementary Figure 3 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
42. Supplementary Figures 1-3 from CD27 Signaling Increases the Frequency of Regulatory T Cells and Promotes Tumor Growth
43. Data from CD27 Signaling Increases the Frequency of Regulatory T Cells and Promotes Tumor Growth
44. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features
45. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
46. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages
47. Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
48. Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver
49. Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease
50. Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.